1-12 of 12
Eriko Suzuki
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Soluble Epoxide Hydrolase As An Anti-Inflammatory Target Of The Thrombolytic Stroke Drug Candidate Smtp-7

Eriko Suzuki, PhD, Naoki Matsumoto, Keita Shibata, PhD, Terumasa Hashimoto, MD, PhD, Kazuo Honda, PhD, Keiji Hasumi, PhD
Journal: Blood
Blood (2013) 122 (21): 2336.
https://doi.org/10.1182/blood.V122.21.2336.2336
Published: 2013
Journal Articles

Rituximab Inhibits the PI3K/Akt Survival Pathway In B-NHL Cells Via Induction of the PTEN Tumor Suppressor: Pivotal Roles of the Inhibition of the PTEN Repressors Snail and YY1

Stavroula Baritaki, PhD, Eriko Suzuki, Ph.D, Mario I. Vega, PhD, Haiming Chen, MD, PhD, James R. Berenson, MD, Benjamin Bonavida, PhD
Journal: Blood
Blood (2010) 116 (21): 3152.
https://doi.org/10.1182/blood.V116.21.3152.3152
Published: 2010
Journal Articles

The Anti-CD 20 Mab R603 Induces PTEN and RKIP Expression in B-NHL Cells: Role in Inhibition of Constitutively Activated Akt and NF-ΚB Survival Anti-Apoptotic Pathways.

Loredana Militello, Stavroula Baritaki, Eriko Suzuki, Mario I. Vega, PhD, Margarita Salcedo, Benjamin Bonavida, PhD
Journal: Blood
Blood (2009) 114 (22): 1970.
https://doi.org/10.1182/blood.V114.22.1970.1970
Published: 2009
Journal Articles

Inhibition of the Akt Pathway in MM Cell Lines by the Anti-TfR-IgG3-Avidin Fusion Protein (Anti-TfR-IgG3-Av): Role in Chemosensitization to CDDP-Induced Apoptosis

Eriko Suzuki, Ph.D., Kazuo Umezawa, Ph.D., Gustavo Helguera, PhD, Tracy R Daniels, Ph.D., Gary Schiller, James R. Berenson, MD, Manuel L Penichet, M.D., Ph.D., Benjamin Bonavida, PhD
Journal: Blood
Blood (2008) 112 (11): 4473.
https://doi.org/10.1182/blood.V112.11.4473.4473
Published: 2008
Journal Articles

Synergy in Apoptosis Is Achieved in B-NHL by the Combination of Rituximab and the Novel Proteasome Inhibitor NPI-0052: Pivotal Role of Induction of the Immune Surveillance Cancer Gene Product RKIP

Mario I. Vega, PhD, Melisa Martinez- Paniagua, Sara Huerta-Yepez, PhD., Eriko Suzuki, Kazuo Umezawa, Kam Yeung, Ph.D., Massimo Libra, Stavroula Baritaki, Michael A. Palladino, PhD, Benjamin Bonavida, PhD
Journal: Blood
Blood (2008) 112 (11): 4973.
https://doi.org/10.1182/blood.V112.11.4973.4973
Published: 2008
Journal Articles

Galiximab Sensitizes Malignant Human B Cell Lines to Apoptosis by Chemotherapeutic Drugs.

Stravroula Baritaki, Eriko Suzuki, Mario Vega, Steffan Ho, Kandasamy Hariharan, Benjamin Bonavida
Journal: Blood
Blood (2007) 110 (11): 3591.
https://doi.org/10.1182/blood.V110.11.3591.3591
Published: 2007
Journal Articles

2-Methoxyestradiol Sensitizes B-NHL Cells to TRAIL-Mediated Apoptosis Via Inhibition of HIF-1α, NF-κ B, YY1 and Induction of DR5 Expression.

Sara Huerta-Yepez, PhD, Mario I. Vega, Ph.D., Stavroula Baritaki, Ph.D., Eriko Suzuki, Theresa La Vallee, Ph.D., Benjamin Bonavida, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 4642.
https://doi.org/10.1182/blood.V108.11.4642.4642
Published: 2006
Journal Articles

Rituximab-Mediated Upregulation of PTEN Expression and Inhibition of Both the PI3K/AKT Pathway and Pleitrophin (PTN) Expression in B-NHL: Roles in Cell Growth Inhibition and Chemosensitization.

Eriko Suzuki, BA, Haiming Chen, M.D., Stavroula Baritaki, Ph.D., Mario I. Vega, Ph.D., Melinda Gordon, Ph.D., Gary J. Schiller, M.D., James Berenson, M.D., Benjamin Bonavida, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 2374.
https://doi.org/10.1182/blood.V108.11.2374.2374
Published: 2006
Journal Articles

Induction of RKIP and Inhibition of the Transcription Repressor YY1 in B-NHL by the Novel Proteasome Inhibitor NPI-0052 and Sensitization to TRAIL-Induced Apoptosis.

Eriko Suzuki, Sara Huerta-Yepez, Ph.D., Stavroula Baritaki, Ph.D., Michael Palladino, Ph.D., Benjamin Bonavida, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 2391.
https://doi.org/10.1182/blood.V108.11.2391.2391
Published: 2006
Journal Articles

Chemosensitization of CDDP-Resistant Multiple Myeloma Cell Lines Following Treatment with Anti-TfR IgG3-Av.

Eriko Suzuki, Xiao-Ho Gan, MD, Kazuo Umezawa, PhD, Gustavo Helguera, PhD, Gary Schiller, MD, Manuel Penichet, MD, PhD, Benjamin Bonavida, PhD
Journal: Blood
Blood (2005) 106 (11): 5119.
https://doi.org/10.1182/blood.V106.11.5119.5119
Published: 2005
Journal Articles

Chemosensitization of Drug and Rituximab-Resistant Daudi B-NHL Clones to Drug-Induced Apoptosis by the Proteasome Inhibitor NPI-0052.

Eriko Suzuki, Ali Jazirehi, PhD, Michael Palladino, PhD, Benjamin Bonavida, PhD
Journal: Blood
Blood (2005) 106 (11): 1521.
https://doi.org/10.1182/blood.V106.11.1521.1521
Published: 2005
Journal Articles

Rituximab-Mediated Inhibition of the PI3K-Akt Survival Signaling Pathway in B-NHL Cell Lines Leading to Downregulation of Bclxl Expression and Chemosensitization.

Eriko Suzuki, Ali R. Jazirehi, PhD, Benjamin Bonavida, PhD
Journal: Blood
Blood (2005) 106 (11): 2830.
https://doi.org/10.1182/blood.V106.11.2830.2830
Published: 2005